In vivo synergy of cardiotoxin and phospholipase A2 from the elapid snake Naja mossambica mossambica.
The lethality of elapid snake venoms is due to toxic polypeptides which are alpha-neurotoxins, phospholipases A2 and cardiotoxins. In contrast to alpha-neurotoxins, less is known about the mode of action of phospholipases A2 and cardiotoxins at a cellular and molecular level, although it has been demonstrated that the hemolytic effect of cardiotoxin and its action on muscle can be accelerated in vitro by phospholipase A2. Here we show that when mice are injected i.v. with phospholipase A2, a significant decrease in survival time is observed if a sub-LD50 amount of cardiotoxin is injected simultaneously. Furthermore, the survival time is drastically reduced when phospholipase A2 (2.3 LD50) is injected first, followed 15 min later by doses of cardiotoxin as small as 0.18 LD50. These results strongly suggest a synergy between the two polypeptides.
D000818:Animals; D004179:Cobra Cardiotoxin Proteins / Q000633:toxicity*; D004357:Drug Synergism; D004546:Elapid Venoms / Q000633:toxicity*; D007928:Lethal Dose 50; D008297:Male; D051379:Mice; D009498:Neurotoxins / Q000633:toxicity; D010740:Phospholipases / Q000633:toxicity*; D010741:Phospholipases A / Q000633:toxicity*; D054467:Phospholipases A2
D004179:Cobra Cardiotoxin Proteins; D004546:Elapid Venoms; D009498:Neurotoxins; D010740:Phospholipases; D010741:Phospholipases A; D054467:Phospholipases A2